PlainRecalls
FDA Drug Low Class III Terminated

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01

Reported: March 28, 2018 Initiated: March 5, 2018 #D-0607-2018

Product Description

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01

Reason for Recall

Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.

Details

Recalling Firm
Pine Pharmaceuticals, LLC
Units Affected
136 units
Distribution
NY only
Location
Tonawanda, NY

Frequently Asked Questions

What product was recalled?
Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01. Recalled by Pine Pharmaceuticals, LLC. Units affected: 136 units.
Why was this product recalled?
Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 28, 2018. Severity: Low. Recall number: D-0607-2018.